Enhanced bactericidal effects of povidone-iodine in the presence of silver ions
- PMID: 39536830
- DOI: 10.1016/j.chemosphere.2024.143734
Enhanced bactericidal effects of povidone-iodine in the presence of silver ions
Abstract
The rising prevalence of antibiotic-resistant infections worldwide necessitates the development of innovative antimicrobial systems for effective pathogen control. This study investigates the synergistic bactericidal effects of a combined system comprising povidone-iodine (PVP-I) and silver ions (Ag(I)). The PVP-I/Ag(I) system exhibited enhanced bactericidal activity against four key surrogate bacterial species: two Gram-negative bacteria, Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa), and two Gram-positive bacteria, Staphylococcus aureus (S. aureus) and Bacillus subtilis (B. subtilis). Our experiments revealed that Ag(I) interacts with iodide ions (I-) to form silver iodide (AgI). This reaction promotes the formation of hypoiodous acid (HOI), a more potent bactericidal agent than other reactive iodine species (RIS), by shifting the equilibrium of RIS released from PVP-I. Under representative conditions ([PVP-I]0 = 1 mg/L, [Ag(I)]0 = 5 μM, pH = 7.3), the concentration of HOI in the PVP-I/Ag(I) system was 2.4-3.9 times higher than in the PVP-I system alone, aligning with theoretical predictions. The bactericidal efficacy of the PVP-I/Ag(I) system was influenced by pH variations, affecting HOI formation. This system represents a promising tool for rapid and effective microbial control, potentially enhancing public health outcomes.
Keywords: Bacterial inactivation; Hypoiodous acid (HOI); Povidone-iodine (PVP–I); Silver ions (Ag(I)); Synergistic effects.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Antimicrobial potency of differently coated 10 and 50 nm silver nanoparticles against clinically relevant bacteria Escherichia coli and Staphylococcus aureus.Colloids Surf B Biointerfaces. 2018 Oct 1;170:401-410. doi: 10.1016/j.colsurfb.2018.06.027. Epub 2018 Jun 18. Colloids Surf B Biointerfaces. 2018. PMID: 29945052
-
Effect of (Ag, Zn) co-doping on structural, optical and bactericidal properties of CuO nanoparticles synthesized by a microwave-assisted method.Dalton Trans. 2021 May 14;50(18):6188-6203. doi: 10.1039/d0dt04405a. Epub 2021 Apr 19. Dalton Trans. 2021. PMID: 33871499
-
Development of Ag/AgX (X = Cl, I) nanoparticles toward antimicrobial, UV-protected and self-cleanable viscose fibers.Carbohydr Polym. 2018 Oct 1;197:227-236. doi: 10.1016/j.carbpol.2018.06.010. Epub 2018 Jun 4. Carbohydr Polym. 2018. PMID: 30007608
-
Iodine-lithium-alpha-dextrin (ILαD) against Staphylococcus aureus skin infections: a comparative study of in-vitro bactericidal activity and cytotoxicity between ILαD and povidone-iodine.J Hosp Infect. 2018 Feb;98(2):134-140. doi: 10.1016/j.jhin.2017.07.013. Epub 2017 Jul 20. J Hosp Infect. 2018. PMID: 28736269
-
Silver Oxide Coatings with High Silver-Ion Elution Rates and Characterization of Bactericidal Activity.Molecules. 2017 Sep 7;22(9):1487. doi: 10.3390/molecules22091487. Molecules. 2017. PMID: 28880225 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical